More than 32 analogs are known to exist within the cannabis plant. Of these, approximately 10 are believed to offer a therapeutic benefit. Noramco is leveraging decades of expertise in controlled substance development, licensing and scale up to supply the pharmaceutical industry with select cannabinoid-based APIs.
These include dronabinol, a synthetic delta-9-tetrahydrocannabinol (delta-9-THC), and Cannabidiol (CBD), another analog of the cannabis plant.
Please note: Noramco only supplies to federally licensed clinical, research, testing and pharmaceutical customers.